Dr. Harry Birmpas is a Patent Agent in the Intellectual Property Practice of the firm's New York office. His technical experience is in general biology, microbiology, and immunology, as well as in cellular and molecular biology. His practice includes the preparation and prosecution of domestic and foreign patents in the fields of biotechnology, biochemistry, genetics, pharmaceuticals, immunology, and drug discovery. His work includes assisting with patent infringement, invalidity and freedom to operate analysis.
Prior to joining Baker Botts, Dr. Birmpas was a technical specialist at an intellectual property law firm. Prior to entering the legal industry, Dr. Birmpas was a Post-Doctoral Fellow at the Frank Reidy Center for Bio-Electrics of Old Dominion University in Norfolk, VA. His research was mainly focused on investigating the role of hsp90 in inflammation in vitro and in vivo, in the mice model of Acute Lung Injury. In addition to his primary research, he studied the potential therapeutic effect of the combinational use of hsp90 inhibitors and nanosecond Pulsed Electric Fields (nsPEFs) in various mice tumor models. Dr. Birmpas’ doctoral research at University of Patras, Greece, was on cancer angiogenesis and the use of synthetic peptides as a potential anti-cancer therapy. He has several years of experience as a teaching assistant for undergraduate courses of cellular biology. Additionally, was the primary supervisor of several pre-graduate students where he planned, guided, and oversaw each individual as they worked towards the completion of their pre-graduate theses.